Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices 45783

Drug Schedule Drug Schedule Aldrich Research Biochemicals, Inc., 4– 3 Strathmore Road, Natick, N-Hydroxy-3,4- I fluid extract (9620) ...... II Massachusetts 01760–2447, made methylenedioxyamphetamine Opium tincture (9630) ...... II application by renewal to the Drug (7402). Opium, granulated (9640) ...... II Enforcement Administration (DEA) to (9143) ...... II (9309) ...... I be registered as a bulk manufacturer of (9312) ...... I (9652) ...... II N-Methyl-3-piperidyl benzilate I Pentobarbital (2270) ...... II the basic classes of controlled (7484). (9715) ...... II substances listed in schedules I and II: Noracymethadol (9633) ...... I (7471) ...... II Norlevorphanol (9634) ...... I Phenmetrazine (1631) ...... II Drug Schedule Normethadone (9635) ...... I Phenylacetone (8501) ...... II Normorphine (9313) ...... I (9730) ...... II Cathinone (1235) ...... I Norpipanone (9636) ...... I Powdered opium (9639) ...... II Methcathinone (1237) ...... I Para-Fluorofentanyl (9812) ...... I Racemethorphan (9732) ...... II Aminorex (1585) ...... I Parahexyl (7374) ...... I (9733) ...... II Alpha-ethyltryptamine (7249) ...... I Peyote (7415) ...... I (9739) ...... II Lysergic acid diethylamide (7315) I Phenadoxone (9637) ...... I Secobarbital (2315) ...... II (7370) ..... I Phenampromide (9638) ...... I (9740) ...... II 4-Bromo-2,5- I Phenomorphan (9647) ...... I (9333) ...... II dimethoxyamphetamine (7391). Phenoperidine (9641) ...... I 4-Bromo-2,5- I Pholcodine (9314) ...... I The company plans to import small dimethoxyphenethylamine (9642) ...... I quantities of the listed controlled (7392). Proheptazine (9643) ...... I substances for the National Institute on 2,5-Dimethoxyamphetamine I (7396). Properidine (9644) ...... I Drug Abuse (NIDA) for research (9649) ...... I 3,4-Methylenedioxyamphetamine I Psilocybin (7437) ...... I activities. (7400). Psilocyn (7438) ...... I No comments or objections have been N-Hydroxy-3,4-methylenedioxy- I Racemoramide (9645) ...... I received. DEA has considered the amphetamine (7402). Tetrahydrocannabinols (7370) ...... I factors in 21 U.S.C. 823(a) and 952(a) 3,4-Methylenedioxy-N- I Thebacon (9315) ...... I and determined that the registration of ethylamphetamine (7404). Thiofentanyl (9835) ...... I Research Triangle Institute to import the 3,4-Methylenedioxymethamphet- I (9750) ...... I basic classes of controlled substances is amine (MDMA) (7405). Trimeperidine (9646) ...... I consistent with the public interest and 1-[1-(2-Thienyl)cyclohexyl]piper- I 1-Phenylcyclohexylamine (7460) .. II with United States obligations under idine (TCP) (7470). 1-Piperidinocyclohexanecarboni- II 1-Benzylpiperazine (BZP) (7493) I trile (8603). international treaties, conventions, or (9200) ...... I (9737) ...... II protocols in effect on May 1, 1971, at Normorphine (9313) ...... I Alphaprodine (9010) ...... II this time. DEA has investigated Amphetamine (1100) ...... II Amobarbital (2125) ...... II Research Triangle Institute to ensure Methamphetamine (1105) ...... II Amphetamine (1100) ...... II that the company’s registration is Nabilone (7379) ...... II (9020) ...... II consistent with the public interest. The 1-Phenylcyclohexylamine (7460) II (9800) ...... II investigation has included inspection Phencyclidine (7471) ...... II (9743) ...... II and testing of the company’s physical Cocaine (9041) ...... II (9050) ...... II security systems, verification of the Codeine (9050) ...... II , bulk (non- II (9058) ...... II dosage forms) (9273). company’s compliance with state and Ecgonine (9180) ...... II (9120) ...... II local laws, and a review of the (9210) ...... II (9334) ...... II company’s background and history. (9220) ...... II (9170) ...... II Therefore, pursuant to 21 U.S.C. 952(a) Meperidine (9230) ...... II (9190) ...... II and 958(a), and in accordance with 21 (9240) ...... II Hcl (9059) ...... II CFR 1301.34, the above named company (9250) ...... II (9801) ...... II is granted registration as an importer of (9300) ...... II Glutethimide (2550) ...... II the basic classes of controlled Thebaine (9333) ...... II (9193) ...... II substances listed. Levo-alphacetylmethadol (9648) .. II (9150) ...... II Carfentanil (9743) ...... II (9226) ...... II Dated: July 29, 2008. Fentanyl (9801) ...... II Levo-alphacetylmethadol (9648) .. II Joseph T. Rannazzisi, Levomethorphan (9210) ...... II Deputy Assistant Administrator, Office of The company plans to manufacture Levorphanol (9220) ...... II Diversion Control, Drug Enforcement reference standards. Lisdexamfetamine (1205) ...... II Administration. Meperidine (9230) ...... II No comments or objections have been Meperidine intermediate-A (9232) II [FR Doc. E8–17966 Filed 8–5–08; 8:45 am] received. DEA has considered the Meperidine intermediate-B (9233) II BILLING CODE 4410–09–P factors in 21 U.S.C. 823(a) and Meperidine intermediate-C (9234) II determined that the registration of Metazocine (9240) ...... II Sigma Aldrich Research Biochemicals, Methadone (9250) ...... II DEPARTMENT OF JUSTICE Inc. to manufacture the listed basic Methadone intermediate (9254) ... II classes of controlled substances is Methamphetamine (1105) ...... II Drug Enforcement Administration consistent with the public interest at Methylphenidate (1724) ...... II this time. DEA has investigated Sigma (9260) ...... II Manufacturer of Controlled Moramide intermediate (9802) ..... II Substances; Notice of Registration Aldrich Research Biochemicals, Inc. to Morphine (9300) ...... II ensure that the company’s registration is Nabilone (7379) ...... II By Notice dated March 19, 2008 and consistent with the public interest. The Opium, raw (9600) ...... II published in the Federal Register on investigation has included inspection Opium extracts (9610) ...... II March 28, 2008, (73 FR 16719), Sigma and testing of the company’s physical

VerDate Aug<31>2005 16:46 Aug 05, 2008 Jkt 214001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 E:\FR\FM\06AUN1.SGM 06AUN1 mstockstill on PROD1PC66 with NOTICES 45784 Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices

security systems, verification of the DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE company’s compliance with state and local laws, and a review of the Drug Enforcement Administration Drug Enforcement Administration company’s background and history. Manufacturer of Controlled Therefore, pursuant to 21 U.S.C. 823, Manufacturer of Controlled Substances; Notice of Application and in accordance with 21 CFR 1301.33, Substances; Notice of Application the above named company is granted Pursuant to § 1301.33(a) of Title 21 of Pursuant to § 1301.33(a) of Title 21 of registration as a bulk manufacturer of the Code of Federal Regulations (CFR), the Code of Federal Regulations (CFR), the basic classes of controlled this is notice that on July 3, 2008, this is notice that on May 28, 2008, substances listed. Cambridge Isotope Lab, 50 Frontage Chattem Chemicals Inc., 3801 St. Elmo Road, Andover, Massachusetts 01810, Dated: July 30, 2008. Avenue, Building 18, Chattanooga, made application by renewal to the Joseph T. Rannazzisi, Tennessee 37409, made application by Drug Enforcement Administration Deputy Assistant Administrator, Office of renewal to the Drug Enforcement (DEA) as a bulk manufacturer of Diversion Control, Drug Enforcement Administration (DEA) as a bulk Morphine (9300), a basic class of Administration. manufacturer of the basic classes of controlled substance listed in schedule [FR Doc. E8–18065 Filed 8–5–08; 8:45 am] controlled substances listed in II. BILLING CODE 4410–09–P schedules I and II: The company plans to utilize small quantities of the listed controlled Drug Schedule substance in the preparation of DEPARTMENT OF JUSTICE analytical standards. 4-Methoxyamphetamine (7411) .... I Any other such applicant, and any Drug Enforcement Administration Difenoxin (9168) ...... I person who is presently registered with Amphetamine (1100) ...... II DEA to manufacture such substance, Manufacturer of Controlled Methamphetamine (1105) ...... II may file comments or objections to the Substances; Notice of Application Methylphenidate (1724) ...... II issuance of the proposed registration Pentobarbital (2270) ...... II pursuant to 21 CFR 1301.33(a). Pursuant to § 1301.33(a) of Title 21 of Codeine (9050) ...... II Any such written comments or Oxycodone (9143) ...... II the Code of Federal Regulations (CFR), objections should be addressed, in Hydrocodone (9193) ...... II this is notice that on July 3, 2008, quintuplicate, to the Drug Enforcement Meperidine (9230) ...... II Chemic Laboratories, Inc., 480 Neponset Administration, Office of Diversion Dextropropoxyphene, bulk (non- II Street, Building 7, Canton, Control, Federal Register Representative Massachusetts 02021, made application dosage forms) (9273). Morphine (9300) ...... II (ODL), 8701 Morrissette Drive, by renewal to the Drug Enforcement Thebaine (9333) ...... II Springfield, Virginia 22152; and must be Administration (DEA) as a bulk Noroxymorphone (9668) ...... II filed no later than October 6, 2008. manufacturer of Cocaine (9041), a basic Alfentanil (9737) ...... II Dated: July 29, 2008. class of controlled substance listed in Sufentanil (9740) ...... II Joseph T. Rannazzisi, schedule II. Fentanyl (9801) ...... II Deputy Assistant Administrator, Office of The company plans to manufacture Diversion Control, Drug Enforcement small quantities of the above listed The company plans to manufacture Administration. controlled substance for distribution to the listed controlled substances in bulk [FR Doc. E8–17962 Filed 8–5–08; 8:45 am] its customers for the purpose of for distribution to its customers. BILLING CODE 4410–09–P research. Any other such applicant, and any Any other such applicant, and any person who is presently registered with DEPARTMENT OF JUSTICE person who is presently registered with DEA to manufacture such substances, DEA to manufacture such substance, may file comments or objections to the Drug Enforcement Administration may file comments or objections to the issuance of the proposed registration issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Manufacturer of Controlled pursuant to 21 CFR 1301.33(a). Substances; Notice of Application Any such written comments or Any such written comments or objections should be addressed, in Pursuant to § 1301.33(a) of Title 21 of objections should be addressed, in quintuplicate, to the Drug Enforcement the Code of Federal Regulations (CFR), quintuplicate, to the Drug Enforcement Administration, Office of Diversion this is notice that on May 28, 2008, Administration, Office of Diversion Control, Federal Register Representative Boehringer Ingelheim Chemicals, Inc., Control, Federal Register Representative (ODL), 8701 Morrissette Drive, 2820 N. Normandy Drive, Petersburg, (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be Virginia 23805, made application by Springfield, Virginia 22152; and must be filed no later than October 6, 2008. renewal to the Drug Enforcement filed no later than October 6, 2008. Administration (DEA) as a bulk Dated: July 29, 2008. manufacturer of the basic classes of Dated: July 28, 2008. Joseph T. Rannazzisi, controlled substances listed in schedule Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of II: Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Diversion Control, Drug Enforcement Administration. Drug Schedule Administration. [FR Doc. E8–17961 Filed 8–5–08; 8:45 am] [FR Doc. E8–17955 Filed 8–5–08; 8:45 am] Amphetamine (1100) ...... II BILLING CODE 4410–09–P Lisdexamfetamine (1205) ...... II BILLING CODE 4410–09–P Methylphenidate (1724) ...... II Methadone (9250) ...... II

VerDate Aug<31>2005 16:46 Aug 05, 2008 Jkt 214001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 E:\FR\FM\06AUN1.SGM 06AUN1 mstockstill on PROD1PC66 with NOTICES